• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部热疗和SR 4233增强了放射性免疫疗法对携带人结肠腺癌异种移植瘤裸鼠的抗肿瘤作用。

Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.

作者信息

Wilder R B, Langmuir V K, Mendonca H L, Goris M L, Knox S J

机构信息

Department of Radiation Oncology, Stanford University, California 94305.

出版信息

Cancer Res. 1993 Jul 1;53(13):3022-7.

PMID:8319209
Abstract

Local hyperthermia and the hypoxic cytotoxin SR 4233 were administered to nude mice with 693 +/- 47 mm3 (mean +/- SE) s.c. HCT-8 human colonic adenocarcinoma xenografts in an attempt to enhance the antitumor effects of radioimmunotherapy. Biodistribution studies revealed preferential binding of NR-Lu-10, a murine monoclonal antibody, to the tumors compared with an isotype-matched control antibody, CCOO16-3.A single injection of 25 microCi 90Y-NR-Lu-10 significantly inhibited tumor growth (control versus 90Y-NR-Lu-10: P = 0.048). The administration of hyperthermia at 41.5 degrees C for 1 h immediately following the injection of 111In-labeled NR-Lu-10 up-regulated tumor-associated antigen expression and increased antibody uptake in the tumors by 73% (P = 0.001) without significantly affecting antibody uptake in normal tissues. However, the heat treatment did not produce a more homogeneous distribution of the antibodies in the tumors and did not significantly enhance the tumor growth delay produced by 90Y-NR-Lu-10 (P = 0.07). The administration of local hyperthermia at 43.0 degrees C for 1 h, on the other hand, had direct cytotoxic effects (P = 0.03) and enhanced the tumor growth delay produced by 90Y-NR-Lu-10 (P = 0.01). SR 4233 also enhanced the tumor growth delay produced by 90Y-NR-Lu-10 (P = 0.03). The greatest antitumor effects were observed when both hyperthermia at 43.0 degrees C and SR 4233 were administered in combination with 90Y-NR-Lu-10 (P = 0.002). No toxicity was produced by the local hyperthermia, and the only toxicities produced by 90Y-NR-Lu-10 and SR 4233 were neutropenia and weight loss.

摘要

对皮下接种有体积为693±47立方毫米(平均值±标准误)的HCT - 8人结肠腺癌异种移植物的裸鼠进行局部热疗,并给予低氧细胞毒素SR 4233,旨在增强放射免疫疗法的抗肿瘤效果。生物分布研究显示,与同型对照抗体CCOO16 - 3相比,鼠单克隆抗体NR - Lu - 10在肿瘤中有优先结合。单次注射25微居里的90Y - NR - Lu - 10可显著抑制肿瘤生长(对照组与90Y - NR - Lu - 10组比较:P = 0.048)。在注射111In标记的NR - Lu - 10后立即进行41.5℃、持续1小时的热疗,上调了肿瘤相关抗原的表达,使肿瘤中抗体摄取增加了73%(P = 0.001),且对正常组织中抗体摄取无显著影响。然而,热处理并未使抗体在肿瘤中的分布更均匀,也未显著增强90Y - NR - Lu - 10所产生的肿瘤生长延迟(P = 0.07)。另一方面,43.0℃、持续1小时的局部热疗具有直接细胞毒性作用(P = 0.03),并增强了90Y - NR - Lu - 10所产生的肿瘤生长延迟(P = 0.01)。SR 4233也增强了90Y - NR - Lu - 10所产生的肿瘤生长延迟(P = 0.03)。当43.0℃热疗和SR 4233都与90Y - NR - Lu - 10联合应用时,观察到最大的抗肿瘤效果(P = 0.002)。局部热疗未产生毒性,90Y - NR - Lu - 10和SR 4233仅产生中性粒细胞减少和体重减轻的毒性。

相似文献

1
Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.局部热疗和SR 4233增强了放射性免疫疗法对携带人结肠腺癌异种移植瘤裸鼠的抗肿瘤作用。
Cancer Res. 1993 Jul 1;53(13):3022-7.
2
The combined use of 131I-labeled antibody and the hypoxic cytotoxin SR 4233 in vitro and in vivo.131I标记抗体与低氧细胞毒素SR 4233在体内外的联合应用。
Radiat Res. 1992 Dec;132(3):351-8.
3
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.实体瘤放射免疫治疗中高传能线密度(LET)的α发射体与低LET的β发射体对比:人结肠癌模型中213Bi标记与90Y标记的CO17-1A Fab'片段的治疗效果及剂量限制毒性
Cancer Res. 1999 Jun 1;59(11):2635-43.
4
Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.使用缓释凝胶对人结肠癌异种移植瘤进行瘤内放射免疫治疗。
Radiother Oncol. 1996 May;39(2):179-89. doi: 10.1016/0167-8140(96)01718-5.
5
Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.用90Y标记的抗癌胚抗原单克隆抗体对人结肠癌异种移植瘤进行放射免疫治疗。
Cancer Res. 1988 Jun 1;48(11):3270-5.
6
Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.联合放射免疫疗法和康普瑞汀a-4 3-O-磷酸酯根除结直肠癌异种移植瘤
Cancer Res. 2001 Jun 15;61(12):4716-22.
7
Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.铟-111和钇-90标记的人单克隆免疫球蛋白M对小鼠人卵巢癌的靶向作用
J Nucl Med. 1998 Mar;39(3):476-84.
8
Interferon enhancement of radioimmunotherapy for colon carcinoma.干扰素增强结肠癌的放射免疫治疗。
Cancer Res. 1991 May 1;51(9):2335-9.
9
Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.(125/131)I-、(186)Re-、(88/90)Y-或(177)Lu标记的抗癌胚抗原单克隆抗体MN-14在结直肠癌源性小腹膜转移小鼠中的生物分布及治疗效果
J Nucl Med. 2004 Jul;45(7):1224-32.
10
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.肾细胞癌放射免疫治疗的优化:用131I、90Y、177Lu或186Re标记单克隆抗体cG250
J Nucl Med. 2004 Feb;45(2):327-37.

引用本文的文献

1
Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy.靶向缺氧:癌症治疗中的缺氧激活前药
Front Oncol. 2021 Jul 29;11:700407. doi: 10.3389/fonc.2021.700407. eCollection 2021.
2
Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer.在胰腺癌异种移植小鼠模型中,轻度热疗可增强西妥昔单抗的递送及抗肿瘤效果。
Cancer Sci. 2016 Apr;107(4):514-20. doi: 10.1111/cas.12888. Epub 2016 Mar 4.
3
Drug delivery and transport to solid tumors.药物向实体瘤的递送与转运。
Pharm Res. 2003 Sep;20(9):1337-50. doi: 10.1023/a:1025785505977.
4
Enhanced efficacy of radioimmunotherapy combined with systemic chemotherapy and local hyperthermia in xenograft model.放射免疫疗法联合全身化疗及局部热疗在异种移植模型中的疗效增强
Jpn J Cancer Res. 2000 May;91(5):573-8. doi: 10.1111/j.1349-7006.2000.tb00983.x.
5
Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas.原发性肾细胞癌中[131I]cG250抗体摄取的肿瘤内异质性的免疫组织化学分析。
Br J Cancer. 1998 Nov;78(9):1208-13. doi: 10.1038/bjc.1998.656.
6
Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion?放射性标记单克隆抗体在肿瘤成像与治疗中的应用:过时了吗?
Eur J Nucl Med. 1995 Jun;22(6):571-80. doi: 10.1007/BF00817285.